IIM
AMRX icon

INTECH Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

INTECH Investment Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$717K Sell
57,702
-39,871
-41% -$535K 0.01% 1168
2025
Q4 		$1.23M Buy
97,573
+1,159
+1% +$13.3K 0.01% 1001
2025
Q3 		$965K Sell
96,414
-32,875
-25% -$295K 0.01% 1184
2025
Q2 		$1.05M Buy
129,289
+17,534
+16% +$132K 0.01% 1171
2025
Q1 		$937K Buy
111,755
+30,700
+38% +$256K 0.01% 1233
2024
Q4 		$642K Buy
81,055
+44,208
+120% +$371K 0.01% 1417
2024
Q3 		$307K Buy
+36,847
New +$288K ﹤0.01% 1509

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return